Postsurgical inflammatory response is not associated with increased serum cystatin C values

Clinical Biochemistry

Volumn 43, Issue 13-14, 2010, Pages 1138-1140

  Åkerfeldt, Torbjörn ^a   Helmersson, Johanna ^a   Larsson, Anders ^a  

^a UPPSALA UNIVERSITY   (Sweden)

Author keywords

C reactive protein; Cystatin C; Glomerular filtration rate; Human; Inflammation; Surgery

Indexed keywords

BIOLOGICAL MARKER; C REACTIVE PROTEIN; CYSTATIN C;

ADULT; ANALYZER; ARTICLE; ASSAY; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CLINICAL ARTICLE; ELECTIVE SURGERY; FEMALE; GLOMERULUS FILTRATION RATE; HIP ARTHROPLASTY; HUMAN; INFLAMMATION; KNEE SURGERY; MALE; ORTHOPEDIC SURGERY; POSTOPERATIVE PERIOD; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SERUM; SURGICAL PATIENT;

AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; CYSTATIN C; FEMALE; HUMANS; INFLAMMATION; MALE; MIDDLE AGED; ORTHOPEDIC PROCEDURES; POSTOPERATIVE PERIOD;

EID: 77956171125     PISSN: 00099120     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clinbiochem.2010.07.004     Document Type: Article

References (21)

1. Cockcroft D.W., Gault M.H. Prediction of creatinine clearance from serum creatinine. Nephron 1976, 16:31-41.
2. Levey A.S., Coresh J., Greene T., Stevens L.A., Zhang Y.L., Hendriksen S., et al. Using standardized serum creatinine values in the modification of diet in renal disease study equation for estimating glomerular filtration rate. Ann Intern Med 2006, 145:247-254.
3. Stevens L.A., Schmid C.H., Zhang Y.L., Coresh J., Manzi J., Landis R., et al. Development and validation of GFR-estimating equations using diabetes, transplant and weight. Nephrol Dial Transplant 2010, 25:449-457.
4. Grubb A.O. Cystatin C-properties and use as diagnostic marker. Adv Clin Chem 2000, 35:63-99.
5. Dharnidharka V.R., Kwon C., Stevens G. Serum cystatin C is superior to serum creatinine as a marker of kidney function: a meta-analysis. Am J Kidney Dis 2002, 40:221-226.
6. Hsu C.Y., Chertow G.M., Curhan G.C. Methodological issues in studying the epidemiology of mild to moderate chronic renal insufficiency. Kidney Int 2002, 61:1567-1576.
7. Sherman D.S., Fish D.N., Teitelbaum I. Assessing renal function in cirrhotic patients: problems and pitfalls. Am J Kidney Dis 2003, 41:269-278.
8. Karawajczyk M., Ramklint M., Larsson A. Reduced cystatin C-estimated GFR and increased creatinine-estimated GFR in comparison with iohexol-estimated GFR in a hyperthyroid patient: A case report. J Med Case Reports 2008, 2:66.
9. Stevens L.A., Schmid C.H., Greene T., Li L., Beck G.J., Joffe M.M., et al. Factors other than glomerular filtration rate affect serum cystatin C levels. Kidney Int 2009, 75:652-660.
10. Al-Malki N., Heidenheim P.A., Filler G., Yasin A., Lindsay R.M. Cystatin C levels in functionally anephric patients undergoing dialysis: the effect of different methods and intensities. Clin J Am Soc Nephrol 2009, 4:1606-1610.
11. Rifkin D.E., Katz R., Fried L.F., Kestenbaum B., Jenny N.S., Newman A.B., et al. Association between baseline kidney function and change in CRP: an analysis of the cardiovascular health study. Nephron Clin Pract 2010, 115:c114-c121.
12. Bastian D., Tamburstuen M.V., Lyngstadaas S.P., Reikeras O. Systemic and local cytokine kinetics after total hip replacement surgery. Eur Surg Res 2008, 41:334-340.
13. Flodin M., Jonsson A.S., Hansson L.O., Danielsson L.A., Larsson A. Evaluation of Gentian cystatin C reagent on Abbott Ci8200 and calculation of glomerular filtration rate expressed in mL/min/1.73m(2) from the cystatin C values in mg/L. Scand J Clin Lab Invest 2007, 67:560-567.
14. Roos J.F., Doust J., Tett S.E., Kirkpatrick C.M. Diagnostic accuracy of cystatin C compared to serum creatinine for the estimation of renal dysfunction in adults and children-a meta-analysis. Clin Biochem 2007, 40:383-391.
15. Stevens L.A., Schmid C.H., Greene T., Li L., Beck G.J., Joffe M.M., et al. Factors other than glomerular filtration rate affect serum cystatin C levels. Kidney Int 2009, 75:652-660.
16. Filiopoulos V., Vlassopoulos D. Inflammatory syndrome in chronic kidney disease: pathogenesis and influence on outcomes. Inflamm Allergy Drug Targets 2009, 8:369-382.
17. Klingenberg R., Hansson G.K. Treating inflammation in atherosclerotic cardiovascular disease: emerging therapies. Eur Heart J 2009, 30:2838-2844.
18. Larsson A., Helmersson J., Hansson L.O., Basu S. Serum cystatin C is associated with other cardiovascular risk markers and cardiovascular disease in elderly men. Int J Cardiol 2008, 125:263-264.
19. Shlipak M.G., Sarnak M.J., Katz R., Fried L.F., Seliger S.L., Newman A.B., et al. Cystatin C and the risk of death and cardiovascular events among elderly persons. N Engl J Med 2005, 352:2049-2060.
20. van Zonneveld A.J., de Boer H.C., van d V., Rabelink T.J. Inflammation, vascular injury and repair in rheumatoid arthritis. Ann Rheum Dis 2010, 69(Suppl 1):i57-i60.
21. Klingenberg R., Hansson G.K. Treating inflammation in atherosclerotic cardiovascular disease: emerging therapies. Eur Heart J 2009, 30:2838-2844.